Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$41,281,169
-$17,587,133 QoQ
Shares Held
787,508
-26.2% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#51
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $2,307,026,460 across 15 Drug Manufacturers - General names. GSK ranks #12 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,217,590 | $588,737,534 | |
| 2 | LLY |
ELI LILLY & Co
|
344,960 | $413,755,406 | |
| 3 | PFE |
Pfizer Inc
|
16,584,797 | $399,361,911 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,370,439 | $176,101,411 | |
| 5 | JNJ |
Johnson & Johnson
|
644,520 | $163,688,742 | |
| 6 | AZN |
Astrazeneca PLC
|
558,835 | $105,966,291 | |
| 7 | NVS |
Novartis AG
|
633,523 | $99,285,724 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
716,459 | $90,517,428 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,281,169 | 787,508 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $58,868,302 | 1,066,648 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $58,571,757 | 1,194,367 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $28,237,991 | 654,263 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $27,411,955 | 713,853 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $31,366,421 | 809,665 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $28,545,398 | 844,039 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $30,108,528 | 736,510 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $26,167,179 | 679,667 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $25,654,865 | 598,434 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $19,626,530 | 529,588 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $21,249,061 | 586,181 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $18,471,819 | 518,289 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $18,070,049 | 507,871 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $26,141,102 | 743,913 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $24,083,569 | 818,334 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $26,061,963 | 610,433 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $16,708,791 | 391,090 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $16,151,812 | 373,424 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $13,833,726 | 369,132 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $10,500,996 | 268,874 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $10,252,891 | 292,900 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $10,811,465 | 299,541 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $9,874,236 | 267,469 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $11,128,260 | 278,159 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $8,669,568 | 233,288 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||